- Q1 2024 Photocure ASA Earnings Call TranscriptMay 15, 2024$5.95Earnings
- Q4 2023 Photocure ASA Earnings Call TranscriptFeb 21, 2024$6.5Earnings
- Q3 2023 Photocure ASA Earnings Call TranscriptNov 08, 2023$5Earnings
- Q2 2023 Photocure ASA Earnings Call TranscriptAug 09, 2023$4.75Earnings
- Q1 2023 Photocure ASA Earnings Call TranscriptMay 10, 2023$10.85Earnings
- Q4 2022 Photocure ASA Earnings Call TranscriptFeb 23, 2023$10.85Earnings
- Q3 2022 Photocure ASA Earnings Call TranscriptNov 02, 2022$10.13Earnings
- Q2 2022 Photocure ASA Earnings Presentation TranscriptAug 10, 2022
- Q1 2022 Photocure ASA Earnings Presentation TranscriptMay 11, 2022
- Photocure ASA at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Q4 2021 Photocure ASA Earnings Presentation TranscriptFeb 23, 2022
- Q3 2021 Photocure ASA Earnings Call TranscriptNov 17, 2021$12.25Earnings
- Q2 2021 Photocure ASA Earnings Call TranscriptAug 11, 2021$15.87Earnings
- Photocure ASA Annual Shareholders Meeting TranscriptMay 20, 2021
- Q1 2021 Photocure ASA Earnings Presentation TranscriptMay 19, 2021
- Q4 2020 Photocure ASA Earnings Call TranscriptMar 03, 2021$14Earnings
- Q3 2020 Photocure ASA Earnings Call TranscriptNov 10, 2020$8.01Earnings
- Q2 2020 Photocure ASA Earnings Call TranscriptAug 18, 2020$7.15Earnings
- Photocure ASA Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Photocure ASA Earnings Call TranscriptMay 07, 2020$6.8Earnings
- Q4 2019 Photocure ASA Earnings Call TranscriptFeb 27, 2020$9.75Earnings
- Q3 2019 Photocure ASA Earnings Call TranscriptNov 07, 2019$6.35Earnings
- Q2 2019 Photocure ASA Earnings Call TranscriptAug 07, 2019$6.5Earnings
- Q1 2019 Photocure ASA Earnings Call TranscriptMay 14, 2019$4.85Earnings
Q2 2023 Photocure ASA Earnings Call Transcript
Well, good morning, good afternoon, everyone. This is Dan Schneider, President and CEO of Photocure. With me today is Erik Dahl, our Chief Financial Officer; and David Moskowitz, our Vice President of Investor Relations. Welcome to Photocure ASA's Second Quarter 2023 Results. Just a reminder, usual disclaimers are in effect for today's presentation.
All right. So if you recall on our earnings call in Q1, we discussed 2 headwinds heading into Q2. The expected phase down of flex BLC, Blue Light Cystoscopy, and the difficult year-over-year comparison, primarily the German hospital stocking that occurred last year in front of the price increase in the European business and also the snapback from the Omicron phase of COVID. So keep that in mind, I think the overall results were good and despite those headwinds, we had 16% revenue growth in Q2 with positive EBITDA from our commercial operations.
Importantly, on a sequential basis, both our North American and European businesses grew off a strong quarter that we reported in Q1. Sequentially
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)